• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP: Dutch officials approve publication of Fouchier's H5N1 study

Shiloh

Editor, Senior Moderator
Source: http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/news/apr2712fouchier.html

Dutch officials approve publication of Fouchier's H5N1 study
Robert Roos * News Editor

Apr 27, 2012 (CIDRAP News) ? The Dutch government has granted virologist Ron Fouchier, PhD, an export license that allows him to submit his much-debated H5N1 transmissibility paper to Science, according to a ScienceInsider report published today.

"Now we can move on," Fouchier told ScienceInsider.

His report details how he and his colleagues developed an H5N1 virus capable of airborne spread among ferrets. Since the study was first described in general terms last September, it has been controversial because of concern that the findings could be exploited to unleash a virus that could spark a human pandemic.

The Dutch government's decision was made by Henk Bleker, minister for agriculture and foreign trade, and announced in a press release (in Dutch) today, according to ScienceInsider. It follows an Apr 23 meeting in The Hague at which government officials discussed the research with scientists and security experts.

The announcement came exactly four weeks after the US National Science Advisory Board for Biosecurity (NSABB) reversed an earlier recommendation and, on a 12-6 vote, endorsed publication of Fouchier's report in full. The US National Institutes of Health endorsed the board's recommendation on Apr 20.

According to ScienceInsider, the Dutch announcement states, "Minister Bleker has weighed all of the benefits and risks of publication of the avian influenza research, and has especially looked at the freedom of research and publication, health, and safety. He has also taken into consideration insights from national and international experts in the areas of security, health, and research; the positive advice of the U.S. National Science Advisory Board on Biosecurity to the US government about publication of the research; and the US government's decision to follow that advice."

Fouchier had opposed the export-permit requirement and at one point vowed he would submit his manuscript without applying for one. But more recently he agreed to apply for the license, while protesting the need for it.

The scientist said he was pleased but not surprised by the government decision and commented that it would have been "strange" if the government had ruled the other way in the wake of the NSABB's recommendation and other developments, according to ScienceInsider.

His revised manuscript will still need to go through peer review at Science, according to previous reports.

When the NSABB endorsed full publication of Fouchier's study, it also voted for full publication of a similar study led by Yoshihiro Kawaoka, DVM, of the University of Wisconsin. The vote on Kawaoka's study, expected to be published in Nature, was unanimous, unlike the decision on Fouchier's.

See also:

Apr 27 ScienceInsider story

Apr 17 CIDRAP News story "Fouchier plans to flout Dutch export law, publish H5N1 study"
 
Back
Top Bottom